Working Groups

Disease Biomarkers

Biomarkers from blood, urine, and tissue samples for utility in NF clinical trials, with standardized sample collection and methodology protocols.

Leadership

About This Group

The goal of the biomarkers working group are to assess biomarkers collected from blood, urine, and tissue samples for their utility in NF clinical trials.  Our group works to (1) define biomarker needs and summarize existing data in NF1, NF2, and Schwannomatosis; (2) outline recommendations for sample collection and biomarker development; and (3) standardize sample collection and methodology protocols where possible to promote comparison between studies by publishing standard operating procedures. Click Here for a Working Group Snapshot

Current group co-leaders: Chetan Bettegowda, MD and Oliver Hanemann, MD, PhD, FRCP · Past group leader: Oliver Hanemann, MD, PhD, FRCP

Current Work

Defining biomarker needs in NF1, NF2, and Schwannomatosis; outlining recommendations for sample collection; publishing standard operating procedures.

Additional Information

No additional sections yet.

Working Group Snapshot & Focus Updates

Defining biomarker needs and summarizing existing data in NF1, NF2, and Schwannomatosis. Outlining recommendations for sample collection and biomarker development. Standardizing sample collection and methodology protocols to promote comparison between studies.

Posted by Chetan Bettegowda, MD

Publications & References

Publication 1 · 2021

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use

Chetan Bettegowda, Meena Upadhayaya, D. Gareth Evans, AeRang Kim, Dimitrios Mathios, Clemens O. Hanemann. Genotype-Phenotype Correlations in Neurofibromatosis and their Potential Clinical Use. Neurology 2021. Aug 2021; 97 (7 Supplement 1) S91-S98; DOI:10.1212/WNL.0000000000012436.

Publication 2 · 2016

Current status and recommendations for biomarkers and biobanking in neurofibromatosis

Hanemann CO, Blakeley JO, Nunes FP, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016 Aug 16;87(7 Suppl 1): S40-8.

Documents & Resources

Biomarkers Group Snapshot Noemails
SnapshotPDF Document· Mar 2019
Disease Biomarkers Snapshot
SnapshotPDF Document· Mar 2019

Join or Contact This Group

Membership is open to all interested parties. Meetings are primarily held by teleconference.

Express Interest

We value your privacy. We use cookies for analytics and to improve the site.